Link Biologics

Private

LondonHealthcare & Life Scienceshttps://linkbiologics.co.uk/

Last Round

Strategic

Sep 12, 2023

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Link Biologics is a biopharmaceutical company that develops protein biologics based on TSG-6 for people living with inflammatory and degenerative disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

protein biologicsTSG-6 proteinbiologic platformclinical stage biotechinflammation modulationdry eye diseaseosteoarthritis treatmentwet AMD treatmentregenerative medicinetissue repairanti-inflammatory biologicsbiotech partnershipspharma licensingophthalmology therapeuticsmusculoskeletal disordersuniversity spin-out

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Link Biologics Comps

Public and private peers based on sector, stage, and business model.

Link Biologics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Link Biologics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Strategic	Sep 12, 2023
Accelerator	Jun 1, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Julia Jones

Fractional CFO

Executive Team

Link Biologics Investors

Notable investors and investment history

Link Biologics investors
Investor	Rounds
Creative Destruction Lab	Accelerator
Théa Open Innovation	Strategic

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 18, 2026
Monthly visitors increased 169% MoM, from 75 to 202.
Dec 7, 2025
Monthly visitors grew 137% MoM, from 41 to 97.

View all signals

Link Biologics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Link Biologics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Link Biologics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range7

Year Founded2020

Last FundingSep 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.